Page last updated: 2024-10-25

dapsone and Bacteremia

dapsone has been researched along with Bacteremia in 2 studies

Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.

Research Excerpts

ExcerptRelevanceReference
"We present a case of fever, brain abscesses, and Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha (TNF-α) therapy in a 21-year-old acne inversa patient currently taking long-term dapsone."3.78Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. ( Asboth, F; Gattringer, KB; Graninger, W; Khalifeh, N; Koreny, M; Lagler, H; Mallouhi, A; Spertini, V; Thalhammer, F; Volc-Platzer, B; Vossen, MG; Willeit, M, 2012)
"Bacteremia was caused by Staphylococcus aureus (23%), Pseudomonas aeruginosa (18%), Escherichia coli (16%), Streptococcus pneumoniae (14%) and others (31%)."1.29Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. ( Edge, MD; Rimland, D, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vossen, MG1
Gattringer, KB1
Khalifeh, N1
Koreny, M1
Spertini, V1
Mallouhi, A1
Willeit, M1
Volc-Platzer, B1
Asboth, F1
Graninger, W1
Thalhammer, F1
Lagler, H1
Edge, MD1
Rimland, D1

Other Studies

2 other studies available for dapsone and Bacteremia

ArticleYear
Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:3

    Topics: Anti-Infective Agents; Antibodies; Bacteremia; Brain Abscess; Dapsone; Gemella; Gram-Positive Bacter

2012
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
    AIDS (London, England), 1996, Volume: 10, Issue:14

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Community-Acquired

1996